First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping.
Ann Thorac Surg
; 112(2): e123-e126, 2021 08.
Article
em En
| MEDLINE
| ID: mdl-33444578
ABSTRACT
The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation. The planning process and surgical technique proved to be complex. This case report can help provide guidance to advanced heart failure teams who encounter patients with the Revivent System who require left ventricular assist device support.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Coração Auxiliar
/
Função Ventricular Esquerda
/
Remodelação Ventricular
/
Insuficiência Cardíaca
/
Procedimentos Cirúrgicos Cardíacos
/
Ventrículos do Coração
Tipo de estudo:
Diagnostic_studies
/
Guideline
Aspecto:
Patient_preference
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
Ann Thorac Surg
Ano de publicação:
2021
Tipo de documento:
Article